The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.00
Bid: 89.80
Ask: 90.80
Change: -2.10 (-2.26%)
Spread: 1.00 (1.114%)
Open: 94.00
High: 94.00
Low: 90.20
Prev. Close: 93.10
CHRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

8 Mar 2021 07:09

RNS Number : 4578R
Chrysalis Investments Limited
08 March 2021
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

 

 

8 March 2021

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Portfolio Update

 

As announced on 26 February 2021, the Company's net asset value ("NAV") per ordinary share was 180.75 pence as of 31 December 2020. The Company subsequently announced on 1 March 2021 an estimated revised valuation of the Company's investment in Klarna Holding AB, due to its funding round, would result in a gross increase in the NAV per ordinary share of approximately 32p (based on Swedish Krona foreign exchange rates as of 26 February 2021) as compared to the Company's last reported NAV per ordinary share.

The Company notes Starling Bank's announcement today of the completion of a major funding round - conducted at a post new-money valuation of £1.3 billion - which represents a material uplift on the Company's carrying value of that asset. It is anticipated that this will lead to a gross NAV per share increase of approximately 6p compared to the Company's last reported NAV per share (calculated on the basis that the achieved valuation on the funding round is applied to revalue the Company's holding of the asset).

The round, which was led by Fidelity Investments and included The Qatar Investment Authority, RailPen Investments and Millennium Management, has raised £272 million of capital to allow Starling to continue its rapid expansion in the UK, as well as launching Starling into Europe and offer M&A flexibility. The funding round is subject to approval by the regulatory authorities.

Starling's recent growth has been exceptional. In February 2020, the bank had approximately £1 billion of customer deposits; as of today, customer deposits are greater than £5.4 billion. In addition, lending has exceeded £2 billion and the bank had achieved its fourth consecutive month of profitability. As of January 2021, run rate net profit was in excess of £1.5 million per month with an annualised run-rate revenue of approximately £145m - an increase of over 400% year on year. Growth continues to be strong with a new customer being added every 39 seconds.

The Company has not participated in the round. However, the Company's Investment Adviser has structured an option, but not an obligation, to allow the Company to participate should it wish to do so in the future. As announced by the Company on 17 February 2021, the Investment Adviser has identified circa £250 million of potential follow-on opportunities for the coming months and this option forms part of that.

Shareholders should note that the gross NAV per ordinary share increases referenced in this announcement and the Company's announcement on 1 March 2021 do not include the fees that may accrue as a result of the changes to this valuation, or any other portfolio company revaluations and associated foreign exchange movements that may be included when the Company next calculates its NAV per ordinary share as at 31 March 2021.

Richard Watts and Nick Williamson (co-Portfolio Managers) comment:

"Starling has shown extraordinary agility to react to the challenging conditions over the last 12 months, as demonstrated by its explosive growth in deposits and profitability. This was facilitated by significant commitment of capital by its shareholders, including Chrysalis Investments, over the course of 2020, which allowed a rapid expansion of its activities.

The endorsement of its valuation and validation of its operating model by new investors underlines the recent progress made. The potential for further profitable growth is highlighted by the fact that Starling managed to drive last year's revenue performance with monthly operating costs staying broadly flat over that period. We believe the expansion of the shareholder base gives Starling a very strong footing from which to continue its growth trajectory, and given its operational gearing dynamics, we remain highly optimistic over its financial prospects.

We believe the likelihood of further value creation for the Company's investors is significant from this asset, and as such, we have negotiated the option for Chrysalis Investments to participate in this round in the coming months."

 

-ENDS-

 

 

For further information, please contact:

 

Media:

Montfort Communications

Charlotte McMullen/ Toto Reissland- Burgh art/ Miles McKenzie

 

 

 

 

+44 (0) 20 3770 7920

chrysalis@montfort.london

 

Jupiter Asset Management:

Magnus Spence

 

+44 (0) 20 3817 1325

Liberum:

Gillian Martin / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown/ Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFIDVTITIIL
Date   Source Headline
2nd May 20247:00 amRNSQuarterly NAV Announcement and Trading Update
22nd Apr 20247:43 amRNSUpdate on claim against Revolution Beauty GroupPLC
15th Mar 20243:05 pmRNSResult of AGM & EGM
14th Mar 202412:28 pmRNSHolding(s) in Company
13th Mar 202411:36 amRNSHolding(s) in Company
11th Mar 20243:21 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSPortfolio Update
1st Mar 20243:01 pmRNSHolding(s) in Company
29th Feb 20249:48 amRNSHolding(s) in Company
8th Feb 20242:52 pmRNSUpdate from QuotedData
31st Jan 20244:46 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSQuarterly NAV Announcement and Trading Update
29th Jan 20247:00 amRNSNotice of AGM and Notice of EGM
29th Jan 20247:00 amRNSAnnual Results
12th Dec 20231:17 pmRNSHolding(s) in Company
11th Dec 202311:25 amRNSHolding(s) in Company
5th Dec 20232:14 pmRNSPortfolio Update
4th Dec 20233:32 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSInvestment Management Arrangements Update
30th Oct 20237:00 amRNSQuarterly NAV Announcement and Trading Update
13th Oct 20237:30 amRNSShareholder Update and Consultation
25th Sep 202310:09 amRNSHolding(s) in Company
13th Sep 20233:44 pmRNSHolding(s) in Company
11th Sep 20235:03 pmRNSHolding(s) in Company
7th Sep 20234:07 pmRNSHolding(s) in Company
21st Aug 202312:17 pmRNSHoldings in Company
31st Jul 20237:00 amRNSQuarterly NAV Announcement and Trading Update
27th Jul 20234:37 pmRNSUpdate from QuotedData
27th Jun 20237:00 amRNSInterim Results
13th Jun 202310:20 amRNSHolding(s) in Company
9th Jun 202312:06 pmRNSHolding(s) in Company
1st Jun 20233:10 pmRNSPortfolio Update
25th May 20239:14 amRNSPortfolio Update
15th May 20237:00 amRNSPortfolio Update
4th May 202310:00 amRNSQuarterly NAV Announcement and Trading Update
19th Apr 20233:16 pmRNSChange of Registered Office
21st Mar 20235:14 pmRNSResult of AGM
1st Mar 20233:15 pmRNSNotice of AGM
10th Feb 202310:34 amRNSHolding(s) in Company
7th Feb 20234:26 pmRNSPortfolio Update
1st Feb 20237:00 amRNSQuarterly NAV Announcement and Trading Update
31st Jan 20237:00 amRNSAnnual Results
6th Jan 20233:20 pmRNSHolding(s) in Company
15th Dec 20221:17 pmRNSHolding(s) in Company
30th Nov 20227:30 amRNSCapital Markets Event
30th Nov 20227:00 amRNSUpdate on Performance Fee Arrangements
25th Nov 202212:18 pmRNSPortfolio Update
21st Nov 20228:30 amRNSQuarterly NAV Announcement and Trading Update
21st Nov 20227:00 amRNSQuarterly NAV Announcement and Trading Update
21st Sep 20222:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.